KRAS and neoplasm: The present study also aimed to verify the differential expression of EGFR, TRKB, KRAS, and HIF-1α, involved in the tumor malignancy process in the subpopulations of TSCs and non-TSCs, and to verify whether the expression of these structures is related to the phenotype of TSCs, as well as the response of HNC to treatment.